250 results on '"Markovic-Plese, Silva"'
Search Results
2. IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.
3. IL-11 induces NLRP3 inflammasome activation, inflammatory cell migration to the CNS and neurotoxicity (P7-6.017)
4. Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
5. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis
6. Microparticle-delivered stimulator of interferon genes (STING) agonist suppresses experimental autoimmune encephalomyelitis (EAE) via expansion of FoxP3 +CD4 +Tregs
7. Humanized Anti-CD25 (Daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β
8. Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)
9. Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing–remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly
10. The role of fractalkine (CX3CL1) in regulation of CD4+ cell migration to the central nervous system in patients with relapsing–remitting multiple sclerosis
11. Therapeutic effect of αCD52 mAb in multiple sclerosis and its animal models is mediated via T-regulatory cells
12. Ana Sotrel, MDFebruary 10, 1943 — May 22, 2022
13. Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells
14. IL-11 induces monocyte inflammasome activation and migration to the CNS in IL-11R+ cells in relapsing remitting multiple sclerosis (RRMS)
15. Single-cell RNA sequence (scRNAseq) analysis of T regulatory cells in relapsing remitting multiple sclerosis (RRMS)
16. Corrigendum to “Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells” [Clinical Immunology 130 (2009) 133–144]
17. Pathogenic features of CD4+CD28– T cells in immune disorders
18. Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study
19. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways
20. The role of IL-11+ monocytes in relapsing-remitting multiple sclerosis (RRMS) and experimental autoimmune encephalomyelitis (EAE) (4715)
21. The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation
22. Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection
23. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy
24. Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response
25. Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis
26. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon [beta]
27. Sclérose en plaques
28. Contributeurs
29. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate
30. Immunopathogenesis of the multiple sclerosis lesion
31. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis
32. Contributors
33. Multiple Sclerosis
34. IL-11 induces surface marker expression and migration of T-lymphocytes
35. Differential expression of soluble cerebrospinal fluid, serum, and cell surface markers in neuromyelitis optica spectrum disorder (5062)
36. IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
37. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis
38. Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair
39. Acute Disseminated Encephalomyelitis After Liver Transplantation
40. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
41. CD4+CD28− costimulation-independent T cells in multiple sclerosis
42. IL-11 Induces Encephalitogenic Th17 cells in Experimental Autoimmune Encephalomyelitis (P2.2-053)
43. Case Report: Combining Dalfampridine with Multicomponent Exercise and Gait Training in a Person with Multiple Sclerosis
44. IL-11 antagonist suppresses Th17 cells-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis (P2.406)
45. IL-11-stimulated Encephalitogenic CD4+ Cells Induce Aggressive RREAE, Mediated via Th17, CD8+, CD19+ Cells and Neutrophils’ Migration to CNS in Passive Transfer RREAE (P2.407)
46. Degenerate t-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis
47. Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder
48. Regulation of Immunomodulatory Cytokine Secretion by IFNb-1a is Mediated through Up-regulation of IRF7-SOCS1 Signaling in Monocytes from Patients with Relapsing-Remitting Multiple Sclerosis
49. IL-11 induces encephalitogenic Th17 cells
50. Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.